Compound Monograph

Hirsutine

Alkaloids Indole Alkaloids Natural (plant-derived)

Hirsutine is a corynanthe-type indole alkaloid of Uncaria (mainly the Chinese gou teng, U. rhynchophylla; also cat's claw and gambir). Its best-characterized action is cardiovascular — a calcium-channel-blocking vasorelaxant with antiarrhythmic properties in isolated tissue — with a notable secondary antiviral signal (anti-influenza A and anti-dengue in vitro). It is chemically distinct from Uncaria's oxindole alkaloids and, despite a shared scaffold with kratom's mitragynine, has no opioid activity. All evidence is preclinical.

Sources · 3

Where Does It Come From?

Hirsutine is a naturally occurring indole alkaloid (corynanthe-type), found in Cat's Claw, Uncaria rhynchophylla and Uncaria gambir. It is well tolerated orally (low toxicity).

Also found in
Uncaria gambir Monograph coming soon
Uncaria rhynchophylla Monograph coming soon

Concentration

Content by Source

Concentrations not reported. No percent-dry-weight or mg/g figures have been published for this compound in its source plants.

Hirsutine at a Glance

Hirsutine is a corynanthe-type indole alkaloid of Uncaria — mainly the Chinese gou teng, and also present in cat’s claw and gambir.

Its best-characterised action is cardiovascular: a calcium-channel-blocking vasorelaxant effect that provides a coherent pharmacological basis for gou teng’s traditional use in hypertension and “liver-yang rising” patterns.

Its research is preclinical.

What It's Used For

Hirsutine is a corynanthe-type indole alkaloid of Uncaria — mainly the Chinese U. rhynchophylla (gou teng), also present in cat’s claw and gambir. Class discipline matters: it is chemically and pharmacologically distinct from the oxindole alkaloids of Amazonian cat’s claw (its co-alkaloid mitraphylline, plus rhynchophylline and pteropodine); and although hirsutine and kratom’s mitragynine share a Rubiaceae corynanthe-indole scaffold, hirsutine has no reported opioid activity — kratom pharmacology must not be read onto it. Its best-characterized action is cardiovascular (a calcium-channel-blocking vasorelaxant), with a notable secondary antiviral signal; all evidence is preclinical.

A well-characterized cardiovascular action:endothelium-independent vasorelaxation via voltage-dependent Ca²⁺-channel blockade, plus antiarrhythmic effects in isolated cardiac tissue 2,4Reference 2Yano S et al. · 1991AnimalCa²⁺-channel-blocking effects of hirsutine, an indole alkaloid from the Uncaria genus, in the isolated rat aortaView study →Reference 4Masumiya H et al. · 1999Effects of hirsutine and dihydrocorynantheine on the action potentials of sino-atrial node, atrium and ventricleView study →.
A genuine antiviral hook:hirsutine inhibits a late step of the dengue lifecycle and is reported potently active against influenza A in vitro 5,6Reference 5Hishiki T et al. · 2017Hirsutine, an indole alkaloid of Uncaria rhynchophylla, inhibits a late step in the dengue-virus lifecycleView study →Reference 6Tietze LF · 1999Highly efficient enantioselective total synthesis of the active anti-influenza-A-virus indole alkaloid hirsutineView study → — but everything is cell/tissue-level, with no human data.
Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. No human isolate data, so scores stay low by design.

Mechanisms

Target / pathwayEffectRelevant to
Voltage-dependent Ca²⁺ channel (vascular smooth muscle)blocked → endothelium-independent vasorelaxation
antihypertensive / vasodilatory
Intracellular Ca²⁺ storesreduced release → lower cytosolic Ca²⁺
vasorelaxation; possible antiviral link
Cardiac action potential (SA node/atrium/ventricle)negative chronotropy, prolonged APD
antiarrhythmic
DENV late lifecycle (assembly/budding/release)inhibited without blocking replication
anti-dengue
Influenza A (H3N2) replicationinhibited (mechanism unresolved)
anti-influenza
NF-κB (p65) → MMP-2/MMP-9; ROCK1/PTEN/PI3K/GSK3β → mPTPsuppressed; pro-apoptotic
anticancer (preclinical)

Pharmacokinetics

Hirsutine’s pharmacokinetics are characterized only in rodents. In rats it undergoes extensive phase-I metabolism (oxidation/demethylation) to multiple metabolites 10Reference 10Nakazawa T et al. · 2006AnimalMetabolites of hirsuteine and hirsutine, the major indole alkaloids of Uncaria rhynchophylla, in ratsView study →; in mice (10 mg/kg IP), tissue distribution is highest in liver and kidney, with low but clearly present brain levels indicating BBB penetration 11Reference 11Zhou Q et al. · 2020AnimalTissue distribution of hirsutine and hirsuteine in mice by UHPLC-MSView study →. A Uncaria-alkaloid review notes generally modest oral bioavailability typical of the class with hepatic/renal handling 12Reference 12Kushida H et al. · 2021Properties, pharmacology and pharmacokinetics of active indole and oxindole alkaloids in Uncaria hookView study →, and there is no validated human pharmacokinetics.

Clinical trials

There are no human trials of isolated hirsutine; all cardiovascular, antiviral and anticancer data are in-vitro or animal, and human Uncaria data pertain to whole extracts, not this molecule.

CompletedPlannedTerminatedPreclinical
—(none, isolate)——Modest(cardiovascular + antiviral)

Last checked: July 2026.

Toxicity & Safety

No documented harm has been reported, but hirsutine is genuinely cardioactive — a calcium-channel blocker that slows the heart and prolongs cardiac action-potential duration — so the plausible risks come from its pharmacology rather than from any toxicity signal.

Safety at a Glance
Low / no toxicityCardiac cautionDrug interactions
  • Not mitragynine. Despite the shared corynanthe-indole scaffold, hirsutine has no reported opioid activity, and kratom’s dependence profile does not apply.
  • Cardioactive at pharmacological exposures. Plausible hypotension, bradycardia and conduction effects follow directly from its calcium-channel blockade.
  • Avoid in pregnancy and lactation. No reproductive data.
  • Additive with cardiovascular drugs. Calcium-channel blockers, antihypertensives and antiarrhythmics.
  • No dedicated toxicology. No LD50 for the isolate was located; cytotoxicity thresholds in the research sit in the low-µM range.
Full Safety & Interactions Detail

Hirsutine has a low verdict on the available preclinical data — no dedicated toxicology or LD50 for the isolate was located, and cytotoxicity thresholds in the antiviral/anticancer work sit in the low-µM range. The honest qualifier is pharmacology, not documented harm: hirsutine is genuinely cardioactive — a Ca²⁺-channel blocker that is negatively chronotropic and prolongs cardiac action-potential duration 2,4Reference 2Yano S et al. · 1991AnimalCa²⁺-channel-blocking effects of hirsutine, an indole alkaloid from the Uncaria genus, in the isolated rat aortaView study →Reference 4Masumiya H et al. · 1999Effects of hirsutine and dihydrocorynantheine on the action potentials of sino-atrial node, atrium and ventricleView study → — so at pharmacological exposures the plausible risks are hypotension, bradycardia and conduction effects, with additive interaction with calcium-channel blockers, antihypertensives and antiarrhythmics. It is not mitragynine: despite the shared corynanthe-indole scaffold, hirsutine has no reported opioid-receptor activity, and kratom’s opioid/dependence profile must not be attributed to it.

Dosage

There is no established human dose for isolated hirsutine, and it is not a standalone supplement. Evidence exists only as in-vitro concentrations (low-µM vasorelaxation; dengue EC50 ~1.9 µM) and animal doses (e.g. mouse 10 mg/kg IP for pharmacokinetics) — none of which is an oral human recommendation.

References

  1. Endo K, et al. (1983). Hypotensive principles of Uncaria hooks. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/6657789/
  2. Yano S, Horiuchi H, Horie S, et al. (1991). Ca²⁺-channel-blocking effects of hirsutine, an indole alkaloid from the Uncaria genus, in the isolated rat aorta. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/1798789/
  3. Horie S, Yano S, Aimi N, et al. (1992). Effects of hirsutine, an antihypertensive indole alkaloid from Uncaria rhynchophylla, on intracellular calcium in rat thoracic aorta. Life Sciences. https://pubmed.ncbi.nlm.nih.gov/1311793/
  4. Masumiya H, Saitoh T, Tanaka Y, et al. (1999). Effects of hirsutine and dihydrocorynantheine on the action potentials of sino-atrial node, atrium and ventricle. Life Sciences. https://pubmed.ncbi.nlm.nih.gov/10597888/
  5. Hishiki T, et al. (2017). Hirsutine, an indole alkaloid of Uncaria rhynchophylla, inhibits a late step in the dengue-virus lifecycle. Frontiers in Microbiology. https://pubmed.ncbi.nlm.nih.gov/28912773/
  6. Tietze LF, Zhou Y (1999). Highly efficient enantioselective total synthesis of the active anti-influenza-A-virus indole alkaloid hirsutine. Angewandte Chemie International Edition. https://pubmed.ncbi.nlm.nih.gov/34182696/
  7. Lou C, Takahashi K, Irimura T, et al. (2014). Identification of hirsutine as an anti-metastatic phytochemical by targeting NF-κB activation. International Journal of Oncology. https://pubmed.ncbi.nlm.nih.gov/25175557/
  8. Zhang R, Li G, Zhang Q, et al. (2018). Hirsutine induces mPTP-dependent apoptosis through the ROCK1/PTEN/PI3K/GSK3β pathway in human lung cancer cells. Cell Death & Disease. https://pubmed.ncbi.nlm.nih.gov/29789524/
  9. Meng J, Su R, Wang L, et al. (2021). Inhibitory effect and mechanism of hirsutine on the proliferation of T-cell leukaemia Jurkat clone E6-1 cells. PeerJ. https://pubmed.ncbi.nlm.nih.gov/33604171/
  10. Nakazawa T, Banba K, Hata K, et al. (2006). Metabolites of hirsuteine and hirsutine, the major indole alkaloids of Uncaria rhynchophylla, in rats. Biological & Pharmaceutical Bulletin. https://pubmed.ncbi.nlm.nih.gov/16880624/
  11. Zhou Q, Ma J, Chen L (2020). Tissue distribution of hirsutine and hirsuteine in mice by UHPLC-MS. Journal of Analytical Methods in Chemistry. https://pubmed.ncbi.nlm.nih.gov/32399311/
  12. Kushida H, Matsumoto T, Ikarashi Y (2021). Properties, pharmacology and pharmacokinetics of active indole and oxindole alkaloids in Uncaria hook. Frontiers in Pharmacology. https://pubmed.ncbi.nlm.nih.gov/34335255/